Former President Trump is reportedly preparing to sign an executive order that would reclassify marijuana, potentially moving it to Schedule III under federal law. This anticipated action has led to a surge in cannabis stocks as investors react to the possibility of eased restrictions. The reclassification could significantly impact cannabis policy in the United States, opening pathways for federal regulations and FDA oversight, though it does not equate to full legalization. While the White House has stated that no final decisions have been made, the growing momentum suggests that major changes in federal cannabis policy may be on the horizon. Industry observers, including dispensary owners, are keenly watching for this historic shift, with some already preparing legislation for full legalization. The news has caused significant fluctuations in the stock market, especially for companies involved in the cannabis sector.